Literature DB >> 27340932

Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.

Wei Zheng1, Yong-Hong Xiong1, Jing Han1, Zhi-Xing Guo1, Yu-Hong Li2, An-Hua Li1, Xiao-Qing Pei1.   

Abstract

OBJECTIVE: This study aimed to investigate the use of contrast-enhanced ultrasonography (CEUS) and time-intensity curves to assess angiogenesis in cervical cancer.
METHODS: 60 patients who were scheduled to undergo radical surgery for biopsy-proven cervical cancers underwent CEUS. Surgical tissue sections from 32 patients who did not receive neoadjuvant chemotherapy were analyzed with CD34 staining to estimate intratumoral microvessel density (MVD). CEUS images were analyzed for maximum intensity (IMAX), rise time (RT), time to peak (TTP) and mean transit time.
RESULTS: Cervical lesions had a higher IMAX and shorter RT and TTP (p < 0.001) than reference regions. There was a linear association between the IMAX of the cervical lesion and the mean intratumoral MVD (r = 0.624, p < 0.001). There were no significant differences in CEUS variables according to histological type, grade and stage.
CONCLUSION: Quantitative CEUS variables have potential use for monitoring perfusion changes in tumours after non-surgical therapy for advanced cervical cancer. ADVANCES IN KNOWLEDGE: The article demonstrates the capability and value of quantitative CEUS as a non-invasive strategy for detecting the perfusion and angiogenic status of cervical cancer. Quantitative CEUS variables have potential use for monitoring tumour response to non-surgical therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27340932      PMCID: PMC5124911          DOI: 10.1259/bjr.20150887

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  40 in total

Review 1.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

Review 2.  Angiogenesis imaging--ultrasound.

Authors:  D Cosgrove
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

3.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Authors:  F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott
Journal:  Ultraschall Med       Date:  2011-08-26       Impact factor: 6.548

Review 4.  MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome.

Authors:  N A Mayr; H Hawighorst; W T Yuh; M Essig; V A Magnotta; M V Knopp
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

5.  Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound.

Authors:  Kenneth Hoyt; Anna Sorace; Reshu Saini
Journal:  Invest Radiol       Date:  2012-03       Impact factor: 6.016

6.  Tumor vascularization in cervical cancer by 3-dimensional power Doppler angiography: correlation with tumor characteristics.

Authors:  Juan Luis Alcázar; Matías Jurado; Guillermo López-García
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

Review 7.  Imaging angiogenesis: applications and potential for drug development.

Authors:  Janet C Miller; Homer H Pien; Dushyant Sahani; A Gregory Sorensen; James H Thrall
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

8.  Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma.

Authors:  K Schlenger; M Höckel; M Mitze; U Schäffer; W Weikel; P G Knapstein; A Lambert
Journal:  Gynecol Oncol       Date:  1995-10       Impact factor: 5.482

9.  Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.

Authors:  R A Cooper; C M West; D P Wilks; J P Logue; S E Davidson; S A Roberts; R D Hunter
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Contrast-enhanced ultrasound in the diagnosis of gallbladder diseases: a multi-center experience.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Ming-De Lu; Xiao-Yan Xie; Wen-Ping Wang; Bing Hu; Kun Yan; Hong Ding; Shao-Shan Tang; Lin-Xue Qian; Bao-Ming Luo; Yan-Ling Wen
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more
  2 in total

1.  Comparison of Contrast-Enhanced Ultrasound and Positron Emission Tomography/Computed Tomography (PET/CT) in Lymphoma.

Authors:  Xiaoyan Niu; Wenbin Jiang; Xiaojuan Zhang; Zhaoyan Ding; Hongwei Xue; Zhenguang Wang; Cheng Zhao
Journal:  Med Sci Monit       Date:  2018-08-10

Review 2.  The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors:  Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.